Analyst IMS Investment Management Services Ltd. trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 31.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,207 shares of the financial services provider’s stock after selling 10,551 shares during the period. Analyst IMS Investment Management Services Ltd. owned approximately 0.05% of iShares Biotechnology ETF worth $3,350,000 at the end of the most re ...